Nathan S. Kline: From the first treatments of psychosis and depression, a 70-year legacy of a pioneer of psychopharmacology

for neuropsychiatric conditions, and comparative studies of iproniazid and other MAOIs, among numerous other manuscripts. Kline's enduring legacy extends beyond psychopharmacology, encompassing early efforts in health informatics to optimize psychiatric logistics and advocacy for the expansion of global mental health care networks, including in low- and middle-income countries.